Dr. Alan McNeill has 30 years of experience in the pharmaceutical industry, both within large Pharma and CROs, in C-14 Radiosynthesis. From this, Alan has developed an in depth understanding of the requirements for a successful and cost-effective labelling strategy to deliver 14C labelled APIs to support pre-clinical and clinical studies. 

Alan holds a PhD in Organic Chemistry from the University of Manchester.